Patient#	Sample#	CO:(HEME, active),	FREE Fe:(HEME, active),	ARNTL:(ARNTL, protein),	ATR:(ATR, protein),	BHLHE40:(BHLHE40, protein),	CHEK1:(CHEK1, protein),	CRY2:(CRY2, protein),	CSNK1E:(CSNK1E, protein),	HEME OXIDASE:(HEME OXIDASE, protein),	NPAS2:(NPAS2, protein),	NONO:(NONO, protein),	PER1:(PER1, protein),	WDR5:(WDR5, protein),	BILIVERDIN:(HEME, active),(HEME OXIDASE, active),	DEC1/BMAL1:(ARNTL, active),(BHLHE40, active),	BMAL/CLOCK/NPAS2	CRY1-2:(CRY1-2, protein),	NR1D1:(NR1D1, protein),	PER1-2:(CSNK1E, active),(PER1-2, protein),	TIMELESS:(TIMELESS, protein),	PER1-2 / CRY1-2:(CRY1-2, active),(PER1-2, active),	PER1-2 / WDR5:(PER1-2, active),(WDR5, active),	PER1/TIMELESS:(PER1, active),(TIMELESS, active),	TIMELESS/CHEK1/ATR:(ATR, active),(CHEK1, active),(DNA damage, active),(TIMELESS, active),	TIMELESS/CRY2:(CRY2, active),(TIMELESS, active),	degradation:(PER1-2, active),	BMAL1/CLOCK:(DEC1/BMAL1, active),(NR1D1, active),(PER1-2 / CRY1-2, active),(PER1/TIMELESS, active),	PER1-2 / CRY1-2 / CK1 epsilon:(CSNK1E, active),(PER1-2 / CRY1-2, active),	PER1-2 /NONO:(NONO, active),(PER1-2, active),	S phase of mitotic cell cycle:(TIMELESS/CHEK1/ATR, active),(absorption of UV light, active),	chromatin modification:(TIMELESS/CHEK1/ATR, active),	histone modification:(PER1-2 / WDR5, active),	
